Anal cancer is a rare type of cancer that develops in the tissues of the anal canal, the short tube at the end of the rectum through which stool leaves the body. While uncommon, affecting only about 11,000 people in the United States each year, it is usually treatable when detected early, especially with today’s modern approaches that combine chemotherapy and radiation.

Understanding Anal Cancer Epidemiology

Anal cancer is considered an uncommon disease when compared to other types of cancer. In the United States, approximately 11,000 people receive this diagnosis annually, making it a relatively rare condition^[2]. Around 7,000 new cases are diagnosed each year according to some estimates, highlighting just how infrequent this cancer truly is^[6]. Despite its rarity, the impact on those affected can be significant, which is why understanding the disease becomes crucial for both patients and healthcare providers.

The disease most commonly affects adults over the age of 50, though people of any age can develop it^[6]. Some sources indicate that people over the age of 75 face a higher likelihood of developing anal cancer^[3]. The cancer does not discriminate by gender, affecting people of any sex, though certain risk factors may make some groups more vulnerable than others.

What Causes Anal Cancer

The exact cause of anal cancer remains unclear for every individual case. However, medical experts have identified a strong connection between this cancer and infection with certain types of human papillomavirus, commonly known as HPV^[2]. HPV is a very common virus that typically spreads through skin-to-skin contact, particularly during sexual activity. What makes this particularly challenging is that most people with HPV never know they have it because the virus usually causes no symptoms at all.

The specific strains of HPV linked to anal cancer are the same high-risk types that can lead to cervical cancer in women. HPV type 16 and type 18 are especially concerning when it comes to cancer development^[4]. Despite the strong association between HPV and anal cancer, it is important to understand that most people infected with HPV will never develop cancer. Similarly, not everyone diagnosed with anal cancer has HPV, though the virus plays a role in the majority of cases^[2].

The cancer develops when cells in the anal canal undergo certain changes in how they function, particularly in how they grow and divide. While HPV can trigger these changes, other factors may also contribute to the transformation of normal cells into cancerous ones. The virus can be transmitted through any skin-to-skin contact of the genital area, as well as through vaginal, anal, or oral sex, and even by sharing sex toys^[3].

Risk Factors That Increase Vulnerability

Beyond HPV infection, several other factors can increase a person’s chances of developing anal cancer. Understanding these risk factors helps individuals and healthcare providers identify who might benefit from closer monitoring or preventive measures.

Sexual behaviors play a significant role in risk. Engaging in unprotected anal sex as the receiving partner increases risk for everyone, regardless of their biological sex. Having many sexual partners throughout one’s lifetime also elevates risk because it increases the likelihood of HPV exposure and infection^[2]. These connections exist not because of moral judgments but simply due to the mechanical transmission routes of the virus.

People with weakened immune systems face considerably higher risk. Those living with HIV are particularly vulnerable because the virus damages the immune system’s ability to fight off other infections like HPV^[2]. Some people with anal cancer have both HPV and HIV infections simultaneously. However, HIV is not the only condition that weakens immunity. People who have received organ transplants and take immunosuppressive medications also face increased risk, as do those with other conditions or treatments that compromise immune function^[2].

A personal history of certain other cancers significantly raises the likelihood of developing anal cancer. Women who have had vulvar, vaginal, or cervical cancer are at higher risk^[4]. This connection likely stems from the fact that these cancers often share the same HPV-related origins.

Smoking cigarettes increases the risk of anal cancer, just as it does for many other types of cancer^[2]. The harmful chemicals in tobacco smoke can damage cells throughout the body, including those in the anal canal. People who smoke are more likely to develop cancer of all kinds, making smoking cessation an important preventive measure.

Not being vaccinated against HPV represents a missed opportunity for protection. The HPV vaccine shields against the virus strains most strongly linked to cancer development^[2]. Since the vaccine has become available, it offers a powerful tool for prevention, though it must typically be administered before exposure to the virus to provide maximum benefit.

Recognizing the Symptoms

Anal cancer produces symptoms that can significantly affect daily life, though these same symptoms often appear in much more common and benign conditions. This overlap can make diagnosis challenging and sometimes leads to delays in seeking medical attention.

The most common symptom is bleeding from the anus or rectum, or noticing blood in the stool^[1][2]. This bleeding might be bright red or darker, depending on where it originates. Because hemorrhoids also cause rectal bleeding, people sometimes mistakenly assume their symptoms stem from this common condition rather than something more serious. This is one reason why any rectal bleeding should be evaluated by a healthcare professional.

Pain or a feeling of fullness in the anal area represents another frequent symptom. Some people describe this as constantly feeling like they need to have a bowel movement, even after just going to the bathroom^[2]. This persistent sensation can be uncomfortable and distracting, interfering with normal activities.

Changes in bowel habits may occur as the cancer grows. People might notice they are going to the bathroom more often than usual, or less frequently^[1]. The appearance of stools may change as well, with some people noticing their stools have become thinner than before^[2]. These changes happen because a growing tumor can narrow the anal canal, affecting how stool passes through.

A visible or palpable lump or mass may develop at the anal opening. Some people discover this while bathing or during routine hygiene^[1][2]. The presence of a lump always warrants medical evaluation, even though many anal lumps are not cancerous.

Itching around the anus, known medically as anal itching, can occur with anal cancer^[1][2]. While this symptom has many possible causes, most of them benign, persistent itching that does not respond to over-the-counter treatments should be checked by a doctor.

It bears repeating that having one or more of these symptoms does not automatically mean you have anal cancer. Hemorrhoids, anal fissures, and other common conditions frequently cause identical symptoms. However, because early detection of cancer dramatically improves treatment outcomes, any persistent or worsening symptoms should prompt a visit to a healthcare provider. Do not wait to see if symptoms resolve on their own if they last more than a few days or become more severe^[2].

Prevention Strategies

While no method guarantees complete prevention of anal cancer, several strategies can significantly reduce risk. These approaches range from lifestyle modifications to medical interventions.

Vaccination against HPV stands as one of the most effective preventive measures available today. The HPV vaccine protects against the virus strains most closely linked to cancer development. All children aged 12 to 13 receive the vaccine as part of routine immunizations in many countries^[3]. The vaccine not only helps prevent anal cancer but also protects against cancers of the mouth and throat, cervical cancer in women, and penile cancer in men^[2].

Certain groups at higher risk receive special recommendations for HPV vaccination. Men aged 45 and under who have sex with men, transgender individuals aged 45 and under with similar risk profiles, sex workers, and people living with HIV all benefit from vaccination^[3]. The vaccine works best when administered before exposure to the virus, which is why childhood vaccination programs aim to protect people before they become sexually active.

Using condoms during sexual activity, particularly during anal sex, helps lower the chances of HPV transmission^[2][3]. While condoms do not provide complete protection against HPV because the virus can infect areas not covered by a condom, they still significantly reduce risk. Keeping sex toys clean and avoiding sharing them also helps prevent virus transmission^[3].

Quitting smoking, or never starting in the first place, reduces cancer risk across the board. For people who currently smoke, cessation programs and support services can help them quit successfully^[2][3]. The benefits of quitting extend far beyond cancer prevention, improving cardiovascular health, respiratory function, and overall wellbeing.

For individuals with multiple risk factors, discussing cancer screening with a healthcare provider makes sense. While routine screening for anal cancer is not standard practice for the general population, people at higher risk might benefit from tests like an anal pap test or anal HPV test^[2]. These tests examine tissue samples for abnormal cells or the presence of HPV virus. The advantage of screening lies in detecting cancer at its earliest stages, or even catching precancerous changes before cancer develops. A healthcare provider can advise whether screening would be appropriate based on individual risk factors.

How the Disease Affects the Body

Understanding the pathophysiology of anal cancer—the physical and biochemical changes it causes in the body—helps explain why symptoms occur and how the disease progresses.

The anal canal is a short tube, measuring only about 1 to 1.5 inches in length, that connects the rectum to the outside of the body^[1][4]. This area is controlled by ring-like muscles called sphincters, which contract to hold stool inside and relax to allow its passage out of the body. The anal canal is formed partly from outer skin layers and partly from intestinal tissue, creating a unique environment where different types of cells meet.

Anal cancer can begin in the lining of the anal canal, called the mucosa, or in the skin outside the anus known as the perianal skin^[4]. The perianal skin contains hair follicles and sweat glands, making it distinct from the mucosal lining inside the canal. Most anal cancers are squamous cell carcinomas, meaning they develop from the flat, scale-like cells that line the anal canal^[2].

When HPV or other factors damage the DNA within anal cells, these cells may begin growing and dividing abnormally. Normal cells have built-in mechanisms that control their growth and cause them to die when they become old or damaged. Cancer cells lose these controls, allowing them to multiply unchecked and avoid normal cell death. As more cancer cells accumulate, they form a tumor that grows within or near the anal canal.

As the tumor expands, it can narrow the anal canal, which explains why people experience thinner stools or difficulty passing bowel movements. The growing mass may also damage nearby blood vessels, causing the bleeding that serves as the most common symptom. When the tumor presses on surrounding nerves, it produces pain or the constant feeling of needing to have a bowel movement.

If left untreated, cancer cells can spread beyond the anal canal to nearby lymph nodes—small, bean-shaped structures that are part of the immune system^[8]. From there, cancer may spread to other parts of the body through the bloodstream or lymphatic system, a process called metastasis. When cancer spreads, it becomes more difficult to treat and can affect the function of other organs.